Big changes are coming for health care and the biopharma industry. What should replace Obamacare? Should we keep investing in the cancer moonshot? What kind of regulation should Congress enact — if any — to respond to public outrage over high drug prices?
We’d like to hear your hopes, fears, and expectations for the Trump presidency. Please weigh in. We may use your comments in a future story.